Skip to content

Building Resilience In Caregivers of Trauma Survivors

Building Resilience In Caregivers of Trauma Survivors

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04293016
Enrollment
300
Registered
2020-03-03
Start date
2022-03-01
Completion date
2024-08-26
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Burnout

Keywords

PTSD, Depression, substance use

Brief summary

The purpose of the study is to examine the role of demographics, pre-existing anxiety, depression, and substance use on caregiver depression anxiety, and substance use following a critical injury to a loved one, evaluate the factors that mediate the effectiveness of traditional psychotherapy using problem solving therapy to reduce depression, anxiety, and substance use and to evaluate the factors that mediate the effectiveness of providing an ICU diary and instruction on that diary to reduce depression, anxiety, and substance use.

Interventions

This group receives current best practice which includes participation in ICU support groups and provision of community support resources

BEHAVIORALProblem solving therapy

This group will receive one on one therapy based on identifying stressors and solutions to those stressors

BEHAVIORALICU diary

This group will be provided with a structured written diary that includes identification of stressors and development of solutions to those stressors

Sponsors

United States Department of Defense
CollaboratorFED
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Must anticipate serving in a Caregiver role after the patient is discharged (A. Must be either a family member or close friend of a patient who has been admitted to the trauma/critical care service ICU B. Must anticipate spending time with the patient in a caregiver or other supportive role (e.g., emotional, social, financial) after the patient is discharged * Caregiver and patient must report English as a primary language * Patient and Caregiver must be able to provide informed consent * Caregiver must be able to provide at least two forms of contact information * Trauma Patient directly admitted to the ICU (Primary cause of admission is trauma, Injury must include trauma to the head/brain or polytrauma, Admitted directly to the hospital, Patient admission of at least 48 hours, Patient is currently admitted to the ICU, Patient is expected to survive more than 96 hours at 48 hours after admission, Patient has an abbreviated injury score greater than 3 (severe, critical, maximum), Fluent in English) * Trauma patient must be able to communicate verbally Exclusion * Does not anticipate serving in a Caregiver role after the patient is discharged * Caregiver is not a close friend or family member of the patient who has been admitted to the ICU * Caregiver does not expect to serve in a supportive role to the patient * Caregiver does not meet inclusion criteria as stated above * Patient is not currently admitted to the ICU and or is not expected to remain in the ICU for 48 hours * Patient is not expected to survive more than 96 hours * Patient is not expected to require assistance prior to discharge * Patient is not between 17 and 65 years of age

Design outcomes

Primary

MeasureTime frameDescription
Short form survey (SF-12)6 months post injuryQuality of life of caregiver as assessed by the short form survey (SF-12).The SF-12 is a 12 item questionnaire with a range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.
Posttraumatic Stress Disorder Checklist (PCL-5)6 months post injuryThe extent to which caregivers have been bothered by PTSD symptoms as assessed by the PTSD Checklist (PCL-5) assessment.The PCL-5 evaluates how much participants have been bothered by PTSD symptoms in the past week (for all assessments during treatment) or the past month (all other assessment time points) as a result of a specific life event. Each item of the PCL-5 is scored on a five-point scale ranging from 0 not at all) to 4 (extremely).
The Hamilton Depression Rating Scale (HAM-D)6 months post injurySymptoms of depression in caregivers as assessed by the The Hamilton Depression Rating Scale (HAM-D).Although the HAM-D form lists 21 items, the scoring is based on the first 17. Eight items are scored on a 5-point scale, ranging from 0 = not present to 4 = severe. Nine are scored from 0(Absent)-2(frequent)

Secondary

MeasureTime frameDescription
Number of days of hospitalization6 months post injuryMedical record based review of hospital readmission
The center for epidemiologic studies of depression (CESD-R )3 months post injuryDepression in caregivers as assessed by the CESD-R tool The CESD-R scale has 20 items and each is measured from 0(not at all) to 4(nearly every day for 2 weeks)
Number of infections post discharge6 months post injuryMedical record based review of number of infections after discharge
PTSD Checklist for (PCL-5) assessment.3 months post injuryThe extent to which caregivers have been bothered by PTSD symptoms as assessed by the PTSD Checklist (PCL-5) assessment.The PCL-5 evaluates how much participants have been bothered by PTSD symptoms in the past week (for all assessments during treatment) or the past month (all other assessment time points) as a result of a specific life event. Each item of the PCL-5 is scored on a five-point scale ranging from 0 not at all) to 4 (extremely).
The Alcohol Use Disorders identification Test (AUDIT):3 months post injuryAlcohol use problems in caregivers as assessed by the AUDIT scale This is a 10-item screening tool and is rated between 0-4-the higher number indicating a worse outcome

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026